U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07190196) titled 'A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnos... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07189884) titled 'Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard... Read More